R Escalante
Overview
Explore the profile of R Escalante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tornero-Ecija A, Navas M, Munoz-Braceras S, Vincent O, Escalante R
J Cell Mol Med
. 2023 May;
27(11):1557-1564.
PMID: 37163371
VPS13A is a lipid transfer protein localized at different membrane contact sites between organelles, and mutations in the corresponding gene produce a rare neurodegenerative disease called chorea-acanthocytosis (ChAc). Previous studies...
2.
Perkins G, Morley P, Nolan J, Soar J, Berg K, Olasveengen T, et al.
Resuscitation
. 2020 May;
151:145-147.
PMID: 32371027
Consensus on Science and Treatment recommendations aim to balance the benefits of early resuscitation with the potential for harm to care providers during the COVID-19 pandemic. Chest compressions and cardiopulmonary...
3.
Bottiger B, Lockey A, Aickin R, Bertaut T, Castren M, de Caen A, et al.
Resuscitation
. 2019 Mar;
138:15-17.
PMID: 30836172
No abstract available.
4.
Bottiger B, Lockey A, Aickin R, Castren M, de Caen A, Escalante R, et al.
Resuscitation
. 2018 Apr;
128:188-190.
PMID: 29679697
"All citizens of the world can save a life". With these words, the International Liaison Committee on Resuscitation (ILCOR) is launching the first global initiative - World Restart a Heart...
5.
Villalobos M, De la Cruz J, Escalante R, Arrebola M, Guerrero A, De La Cuesta F
Pharmacology
. 2003 Jul;
69(1):44-50.
PMID: 12886030
The aim of this study was to compare the effects of a new thromboxane synthase inhibitor, camonagrel, on platelet aggregation and platelet-subendothelium interaction under flow conditions, in comparison with a...
6.
De la Cruz J, Villalobos M, Escalante R, Guerrero A, Arrebola M, De La Cuesta F
Br J Pharmacol
. 2002 Nov;
137(7):1082-8.
PMID: 12429581
1. Drugs that inhibit TxA(2) synthesis are used to reduce platelet aggregation. The aim of this study was to compare the effects of a cyclo-oxygenase (COX) inhibitor (acetylsalicylic acid, ASA),...
7.
Escalante R, Sastre L
Biochem Biophys Res Commun
. 2001 Jul;
285(3):820-4.
PMID: 11453666
The MADS-box-containing gene srfA from Dictyostelium discoideum codes for a putative transcription factor that plays multiple roles in the development of this social amoeba. We have investigated the regulation of...
8.
Escalante R, Vicente J, Moreno N, Sastre L
Dev Biol
. 2001 Jul;
235(2):314-29.
PMID: 11437439
srfA displays a complex temporal and cell type-specific pattern of expression in Dictyostelium and is expressed by most of its cell types at some stage of their development. This complexity...
9.
Escalante R, Vicente J
Int J Dev Biol
. 2001 Feb;
44(8):819-35.
PMID: 11206323
In Dictyostelium, development begins with the aggregation of free living amoebae, which soon become organized into a relatively simple organism with a few different cell types. Coordinated cell type differentiation...
10.
Saez A, Escalante R, Sastre L
Mol Biol Evol
. 2000 Mar;
17(2):235-50.
PMID: 10677846
We previously reported that the Na/K-ATPase alpha 1 subunit coding gene showed signs of being a very polymorphic locus in Artemia franciscana. This species is adapted to highly saline waters,...